Uncategorized Archives - Page 885 of 986

WednesdaySep 20, 2017 3:55 pm

Moxian, Inc. (NASDAQ: MOXC) O2O Commerce Marketplace Makes Mobile Payments Easier

Provider of mobile payment tools Using social media to drive ecommerce Marketplace that links offline and online A look at Nielsen’s latest Global Mobile Money Report (http://nnw.fm/fWG5j) shows that Moxian, Inc. (NASDAQ: MOXC) is in the right place at the right time. The Nielsen report shows that close to half of Chinese consumers are likely to use a mobile device to pay their bills in bars, restaurants and retail stores, a far, far higher number than in the U.S. or Europe. This revealing statistic, coupled with Moxian’s position at the nexus of online retail establishments and their brick-and-mortar counterparts, gives…

WednesdaySep 20, 2017 3:22 pm

Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) is “One to Watch”

Amid a continued boom in the growing cannabis sector, Canada is moving rapidly toward legalization as the U.S. continues to foot drag at the federal level, leading many sector analysts to conclude that it’s the Canadian companies who might benefit the most as an underlying shift toward medical and recreational use continues. Out of a tiny handful of just 58 Health Canada-licensed producers, vertically integrated Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) stands out as a one of the fastest growing cultivators and pharma developers, having also obtained authorization to produce cannabis oils. While sales of dried marijuana intended for smoking…

WednesdaySep 20, 2017 10:39 am

Findit, Inc. (FDIT) Scores Apple Approval; Download Available in Apple App Store

Findit, Inc. (OTC: FDIT) recently announced that its interactive social media campaign management Findit App is now available for download on iOS devices in the Apple® App Store. “Having Apple approve our app for IOS users is one more step closer to providing anyone who wants to reach more people on the web the ability to do so,“ Findit, Inc. CEO and President Raymond Firth stated in a news release, noting that the app is also available in the Google Play Store for Android devices. “We are really pulling everyone together that has the desire to have their content seen…

WednesdaySep 20, 2017 10:06 am

The Green Organic Dutchman Rides on Quality Medical Cannabis, Private Placement and Strong Leadership

The Green Organic Dutchman (“TGOD”), a 100-percent owned subsidiary of The Green Organic Dutchman Holdings Ltd., produces high-quality medical marijuana. Its organic medical cannabis is farm grown and pesticide-free. There are many factors in favor of the company. The demand in a legal national market, consumer preference for organic foods and products of all kinds and a recent $20 million private placement are all positive signs. Also, TGOD is among a select group of companies licensed to cultivate medical cannabis by Health Canada under the Access to Cannabis for Medical Purposes Regulations. Those interested in investing should contact TGOD directly…

TuesdaySep 19, 2017 4:08 pm

The Green Organic Dutchman Holdings Ltd. Announces $20M Private Placement as Company Moves toward Expansion

Company has, to date, raised $41.5 million and has more than 2,400 shareholders Has one of the largest licensed land parcels in Canada, situated on 100 acres Offers organically grown, pesticide-free medical marijuana under Canada’s ACMPR The Green Organic Dutchman Holdings Ltd. (“TGOD”), a Canadian company engaged in producing farm-grown, high-quality organic medical cannabis using craft growing, all natural, organic principles, announced on September 11 (http://nnw.fm/b4N9N) that it has entered into an agreement with a syndicate led by PI Financial Corp. to complete a private placement offering of units. The syndicate will offer, on a commercially reasonable effort basis, 4,242,500…

TuesdaySep 19, 2017 3:29 pm

At ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF), Medicinal Cannabinoid Quality and Safety are Founding Principles

Producer of consistent, standardized medicinal cannabis Menu of cannabis strains with varying CBD:THC ratios ABcann’s CBD-Med is one of Canada's highest-CBD products In an interview with Cantech Letter (http://nnw.fm/IOcj0), Aaron Keay, CEO of ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF), talked about the factors that triggered the genesis of the company, one of Canada’s trailblazing producers of medicinal cannabis. Ken Clement, the founder of ABcann, with his wealth of experience and knowledge, had observed the variability in consistency and potency of cannabis that was currently available. Although, in general, not much of a bother to recreational users, to those using cannabis…

TuesdaySep 19, 2017 11:25 am

Greenkraft, Inc. (GKIT) is “One to Watch”

Greenkraft, Inc. expects to realize well over $1 million of new revenue in 2017 Expansion plans include construction of larger manufacturing facility to accommodate increasing demand for Greenkraft’s alternative fuel commercial trucks A new line of larger, heavy duty G3 and G4 commercial trucks are coming soon Greenkraft vehicles meet EPA and CARB emission standards through use of clean alternative fuels Greenkraft, Inc. (OTCQB: GKIT) is a nationally recognized company specializing in the production of alternative fuel automotive products, including engines and commercial trucks. Located in Santa Ana, California, the company’s mission is to provide clean, green, energy efficient automotive…

TuesdaySep 19, 2017 9:00 am

What it Takes to Thrive in Canada’s Multi-Billion-Dollar Marijuana Industry

NetworkNewsWire Editorial Coverage: Canadian medicinal marijuana sales could exceed $8 billion by 2024, as forecast by Canaccord Genuity Group’s November 2016 market research report. ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) (ABcann Profile) is considered one of Canada’s strongest growers, boasting a customer retention rate of 94.7 percent, no history of product recalls, and computer-controlled production that have strengthened the company’s reputation for its pharmaceutical-grade cannabis. While ABcann already occupies a strong position, its leadership team continues to draw on pharmaceutical and capital markets experience to help achieve broader corporate goals. These advantages separate ABcann from other producers such as…

TuesdaySep 19, 2017 9:00 am

Advances in Drug Delivery Hold the Promise of Reducing Inevitable Side Effects

NetworkNewsWire Editorial Coverage: The hazards of pharmacology have hardly changed since Paracelsus, a famous Renaissance physician, astoundingly declared that it was only the dosage that separated a medicine from a poison, bundled with adverse side effects. Despite considerable advances in medicine, many medications are still as injurious as their Renaissance precursors. Nevertheless, recent developments in drug delivery technologies increasingly suggest that safer, more efficient treatment options are on the horizon. At the core of this potential are cannabinoids. Developments in this rapidly growing segment of the medical marijuana market are pioneered by a vast number of innovators, including Lexaria Bioscience…

MondaySep 18, 2017 3:00 pm

India Globalization Capital, Inc. (NYSE: IGC) Reports Promising Progress of Cannabis-Based Alzheimer’s Drug Candidate

IGC is the only publicly traded cannabis stock with patent filings for treating Alzheimer’s disease Company has a first-mover advantage in phytocannabinoid-based combination therapy Alzheimer’s is America’s most expensive disease, costing the country an estimated $259 billion in 2017 It is considered America’s most expensive disease, projected to cost an estimated $259 billion in the United States in 2017 and as much as $1.1 trillion by 2050 (http://nnw.fm/Owr4D). It is not cancer, and it is not AIDS. It is Alzheimer’s disease. This devastating chronic neurodegenerative disease is the most common cause of dementia among older adults and is the sixth-leading…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Category: Uncategorized